TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression

Leuk Lymphoma. 2022 Nov;63(11):2735-2738. doi: 10.1080/10428194.2022.2087070. Epub 2022 Jun 18.

Authors

Emily Symes¹, Peng Wang¹, Angela M Lager², Michael R Bishop^{2

3}, Barina Aqil⁴, Girish Venkataraman¹

Affiliations

¹ Department of Pathology, University of Chicago, Chicago, IL, USA.
² Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
³ The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.
⁴ Division of Hematopathology, Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

PMID: 35719104
DOI: 10.1080/10428194.2022.2087070

No abstract available

Publication types

Letter

MeSH terms

Cell Transformation, Neoplastic / genetics
Cell Transformation, Neoplastic / pathology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
Lymphoma, Large B-Cell, Diffuse* / diagnosis
Lymphoma, Large B-Cell, Diffuse* / genetics
Lymphoma, Large B-Cell, Diffuse* / metabolism
Programmed Cell Death 1 Receptor / metabolism
Tumor Suppressor Protein p53

Substances

Programmed Cell Death 1 Receptor
TP53 protein, human
Tumor Suppressor Protein p53